Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between fluoride concentrations and spontaneous humeral fracture in first-lactation dairy cows: results from two New Zealand studies.

New Zealand veterinary journal·2024
Same author

Ulcerative stomatitis associated with yellow bristle grass in New Zealand dairy cows.

New Zealand veterinary journal·2024
Same author

Farm management and husbandry practices associated with spontaneous humeral fractures in New Zealand dairy heifers.

New Zealand veterinary journal·2023
Same author

Enzootic calcinosis in Toggenburg goats in New Zealand.

New Zealand veterinary journal·2023
Same author

Smooth muscle hamartoma in a castrated male red deer (<i>Cervus elaphus</i>) in New Zealand.

New Zealand veterinary journal·2023
Same author

Infrared spectroscopy of serum fails to identify early biomarker changes in an equine model of traumatic osteoarthritis.

Osteoarthritis and cartilage open·2022

Related Experiment Video

Updated: Mar 25, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K

Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.

A S Wehrle-Martinez1, K E Dittmer2, D Aberdein2

  • 1Institute of Veterinary, Animal and Biomedical Sciences, Massey University, Palmerston North, New Zealand ASWehrle@hotmail.com.

Veterinary Pathology
|March 2, 2016
PubMed
Summary

Osteocalcin (OC) shows high sensitivity for canine osteosarcoma (OSA) but cannot distinguish it from chondrosarcoma. Osteonectin (ON) is not specific for OSA diagnosis in dogs.

Keywords:
bone tumorscaninechondrosarcomaimmunohistochemistryosteocalcinosteoidosteonectinosteosarcoma

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.0K

Related Experiment Videos

Last Updated: Mar 25, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.8K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

12.0K

Area of Science:

  • Veterinary Pathology
  • Oncology
  • Biomarkers

Background:

  • Osteosarcoma (OSA) is the most common primary bone tumor in dogs, accounting for up to 90% of cases.
  • Accurate diagnosis of OSA is crucial for effective treatment and prognosis in canine patients.
  • Osteocalcin (OC) and osteonectin (ON) are bone matrix proteins that may serve as diagnostic markers.

Purpose of the Study:

  • To evaluate the immunoreactivity of osteocalcin (OC) and osteonectin (ON) in canine osteosarcoma (OSA).
  • To assess the impact of different decalcification agents on OC and ON immunoreactivity.
  • To determine the diagnostic utility and specificity of OC and ON for canine OSA.

Main Methods:

  • Immunohistochemical evaluation of OC and ON in 23 canine OSAs and 14 other bone tumors (chondrosarcomas, fibrosarcomas, hemangiosarcomas, histiocytic sarcomas).
  • Assessment of immunoreactivity following decalcification with ethylenediaminetetraacetic acid (EDTA), formic acid, or hydrochloric acid (HCl).
  • Calculation of sensitivity and specificity for OC and ON in diagnosing canine OSA.

Main Results:

  • Osteocalcin (OC) immunoreactivity was found in 83% of OSAs and 100% of chondrosarcomas, yielding 83% sensitivity and 71% specificity for OSA.
  • Osteonectin (ON) showed 100% sensitivity but lacked specificity, with immunoreactivity present in all OSA and non-OSA samples.
  • No significant differences in OC or ON immunoreactivity were observed between the decalcification agents used.

Conclusions:

  • Osteocalcin (OC) demonstrates high sensitivity for canine OSA but cannot differentiate it from chondrosarcoma.
  • The lack of osteoid immunoreactivity in most OSA cases limits OC's practical diagnostic utility.
  • Osteonectin (ON) lacks specificity and has minimal practical application for diagnosing canine OSA.